Fuller & Thaler Asset Management’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-967,480
| Closed | -$28.3M | – | 776 |
|
|
2017
Q3 | $28.3M | Buy |
967,480
+1,302
| +0.1% | +$36.5K | 0.35% | 88 |
|
|
2017
Q2 | $25.4M | Buy |
966,178
+5,115
| +0.5% | +$126K | 0.33% | 85 |
|
|
2017
Q1 | $22.5M | Buy |
961,063
+70,141
| +8% | +$1.73M | 0.31% | 86 |
|
|
2016
Q4 | $22.4M | Buy |
890,922
+35,972
| +4% | +$908K | 0.34% | 84 |
|
|
2016
Q3 | $24M | Sell |
854,950
-5,270
| -0.6% | -$135K | 0.4% | 80 |
|
|
2016
Q2 | $21.2M | Buy |
860,220
+141,928
| +20% | +$3.52M | 0.36% | 78 |
|
|
2016
Q1 | $15.9M | Buy |
718,292
+87,410
| +14% | +$2.33M | 0.31% | 82 |
|
|
2015
Q4 | $22.1M | Buy |
630,882
+147,675
| +31% | +$4.63M | 0.47% | 69 |
|
|
2015
Q3 | $13.8M | Buy |
483,207
+95,759
| +25% | +$3.22M | 0.36% | 80 |
|
|
2015
Q2 | $12.9M | Buy |
387,448
+62,465
| +19% | +$1.92M | 0.36% | 77 |
|
|
2015
Q1 | $9.16M | Buy |
324,983
+45,788
| +16% | +$1.14M | 0.29% | 85 |
|
|
2014
Q4 | $5.78M | Buy |
279,195
+49,125
| +21% | +$1.17M | 0.21% | 111 |
|
|
2014
Q3 | $5.62M | Buy |
230,070
+24,169
| +12% | +$641K | 0.24% | 112 |
|
|
2014
Q2 | $5.89M | Sell |
205,901
-162,132
| -44% | -$4.51M | 0.25% | 117 |
|
|
2014
Q1 | $10.3M | Sell |
368,033
-7,088
| -2% | -$174K | 0.5% | 64 |
|
|
2013
Q4 | $8.06M | Sell |
375,121
-181,083
| -33% | -$3.29M | 0.44% | 82 |
|
|
2013
Q3 | $7.38M | Sell |
556,204
-36,777
| -6% | -$495K | 0.44% | 87 |
|
|
2013
Q2 | $8.22M | Buy |
+592,981
| New | +$8.4M | 0.58% | 50 |
|
Fuller & Thaler Asset Management's PMC Position: Q4 2017 in Review
Fuller & Thaler Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 967,480 shares — an estimated $28.3M sold.
Fuller & Thaler Asset Management first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $28.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Fuller & Thaler Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Fuller & Thaler Asset Management sold 967,480 PharMerica Corporation shares in Q4 2017, an estimated $28.3M.
- Fuller & Thaler Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Fuller & Thaler Asset Management's PharMerica Corporation position peaked at $28.3M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Fuller & Thaler Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.